Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-04 · accession 0001127602-24-000835 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-04 | 2024-01-04 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $86.98 | -15.7K | 147.0K | -10% | -$1.36M |
| D | 2024-01-04 | 2024-01-04 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +11.7K | 162.7K | +8% | +$93.0K |
| D | 2024-01-04 | 2024-01-04 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $0.00 | -11.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-04 | S | D | 11,678 | $86.98 | 150,973 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-04 | M | A | 11,678 | $7.96 | 162,651 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-04 | S | D | 4,000 | $86.99 | 146,973 | D | — | — | |
| 4 | Derivative | Incentive Stock Option (Right to Buy) | 2024-01-04 | M | D | 11,678 | $0.00 | 0 | D | $7.96 · 2015-03-26 to 2025-02-26 | 11,678 Common Stock |